Skip to main content
. 2020 Mar 4;10(9):3905–3924. doi: 10.7150/thno.38640

Figure 8.

Figure 8

A proposed model depicting the molecular mechanism by which Serelaxin activates Notch signaling pathway to inhibit TGFβ-induced SMAD2/3 phosphorylation to restore the RXFP1 expression via histone modifications.